Madigan L. Bedard , Xi-Ping Huang , Jackson G. Murray , Alexandra C. Nowlan , Sara Y. Conley , Sarah E. Mott , Samuel J. Loyack , Calista A. Cline , Caroline G. Clodfelter , Nabarun Dasgupta , Brian Krumm , Bryan L. Roth , Zoe A. McElligott
{"title":"对 \"赛拉嗪是卡巴阿片受体的激动剂,对阿片拮抗剂表现出性别特异性反应 \"的更正[《成瘾神经科学》,第11卷,2024年6月,100155]","authors":"Madigan L. Bedard , Xi-Ping Huang , Jackson G. Murray , Alexandra C. Nowlan , Sara Y. Conley , Sarah E. Mott , Samuel J. Loyack , Calista A. Cline , Caroline G. Clodfelter , Nabarun Dasgupta , Brian Krumm , Bryan L. Roth , Zoe A. McElligott","doi":"10.1016/j.addicn.2024.100166","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":72067,"journal":{"name":"Addiction neuroscience","volume":"12 ","pages":"Article 100166"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772392524000257/pdfft?md5=a8e0befd6e4bd98cdfdcf6ca34450d32&pid=1-s2.0-S2772392524000257-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Corrigendum to “Xylazine is an agonist at kappa opioid receptors and exhibits sex-specific responses to opioid antagonism” [Addiction Neuroscience, Volume 11, June 2024, 100155]\",\"authors\":\"Madigan L. Bedard , Xi-Ping Huang , Jackson G. Murray , Alexandra C. Nowlan , Sara Y. Conley , Sarah E. Mott , Samuel J. Loyack , Calista A. Cline , Caroline G. Clodfelter , Nabarun Dasgupta , Brian Krumm , Bryan L. Roth , Zoe A. McElligott\",\"doi\":\"10.1016/j.addicn.2024.100166\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":72067,\"journal\":{\"name\":\"Addiction neuroscience\",\"volume\":\"12 \",\"pages\":\"Article 100166\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2772392524000257/pdfft?md5=a8e0befd6e4bd98cdfdcf6ca34450d32&pid=1-s2.0-S2772392524000257-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Addiction neuroscience\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2772392524000257\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Addiction neuroscience","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772392524000257","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Corrigendum to “Xylazine is an agonist at kappa opioid receptors and exhibits sex-specific responses to opioid antagonism” [Addiction Neuroscience, Volume 11, June 2024, 100155]